Niger vs United States of America: Confirmed cases of MDR-TB started treatment for MDR-TB
Niger
94.0%
in 2012
United States of America
99.0%
in 2012
Niger rank
26th
United States of America rank
24th
Confirmed cases of MDR-TB started treatment for MDR-TB over time
- Niger
- United States of America
How they compare
United States of America currently reports 99.0% against 94.0% in Niger, a difference of 5.0%.
That makes United States of America's figure about 1.1 times Niger's.
The two have swapped places 1 time across 5 shared years of data; in 2008 it was Niger ahead.
Niger ranks 26th and United States of America ranks 24th of 54 countries.
Across the 2 decades both report, Niger averaged higher in 1 and United States of America in 1.
Head to head by decade
| Decade | Niger | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 108.5% | 56.5% | 52.0% | Niger |
| 2010s | 83.7% | 94.3% | 10.7% | United States of America |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher confirmed cases of mdr-tb started treatment for mdr-tb, Niger or United States of America?
- United States of America, at 99.0% against 94.0% in Niger as of 2012.
- What is the difference in confirmed cases of mdr-tb started treatment for mdr-tb between Niger and United States of America?
- 5.0%, with United States of America ahead.
- How many years of comparable data are there for Niger and United States of America?
- 5 years are reported by both, from 2008 to 2012.
- How do Niger and United States of America rank globally for confirmed cases of mdr-tb started treatment for mdr-tb?
- Niger ranks 26th and United States of America ranks 24th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Confirmed cases of MDR-TB started treatment for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.